2 Supermarket Stocks in Focus Amid Robust Industry Trends — Positive
KR WMT Zacks Investment Research — May 09, 2025The Zacks Retail - Supermarkets industry is capitalizing on consistent consumer demand and embracing AI-driven omnichannel innovations, positioning WMT and KR for long-term growth.

MGIC Investment Corporation (MTG) Hit a 52 Week High, Can the Run Continue? — Positive
MTG Zacks Investment Research — May 09, 2025MGIC (MTG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

UGI Corporation (UGI) Soars to 52-Week High, Time to Cash Out? — Positive
UGI Zacks Investment Research — May 09, 2025UGI (UGI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Limbach Holdings, Inc. (LMB) Hits Fresh High: Is There Still Room to Run? — Positive
LMB Zacks Investment Research — May 09, 2025Limbach (LMB) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Universal Technical Institute Inc (UTI) Hits Fresh High: Is There Still Room to Run? — Positive
UTI Zacks Investment Research — May 09, 2025Universal Technical (UTI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Cytokinetics, Incorporated Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - CYTK — Neutral
CYTK Accesswire — May 09, 2025NEW YORK, NY / ACCESS Newswire / May 9, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cytokinetics, Incorporated ("Cytokinetics, Incorporated") (NASDAQ:CYTK) concerning possible violations of federal securities laws. BioPharma Dive published a report on Cytokinetics on May 2, 2025, and stated that, "The Food and Drug Administration has delayed an approval decision on Cytokinetics' experimental hypertrophic obstructive cardiomyopathy drug aficamten so it can have more time to review the company's proposed risk management plan.

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Geron Corporation (GERN) Shareholders — Neutral
GERN Accesswire — May 09, 2025NEW YORK, NY / ACCESS Newswire / May 9, 2025 / If you suffered a loss on your Geron Corporation (NASDAQ:GERN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/geron-corporation-lawsuit-submission-form?prid=147767&wire=1 or contact Joseph E. Levi, Esq.

Humana Inc. (HUM) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates — Neutral
HUM Accesswire — May 09, 2025NEW YORK, NY / ACCESS Newswire / May 9, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Humana Inc. ("Humana Inc.") (NYSE:HUM) concerning possible violations of federal securities laws. On May 1, 2025, the U.S. Department of Justice announced it had filed a False Claims Act complaint against several health insurance companies and insurance broker organizations, including Humana.

Lost Money on Compass Diversified (CODI)? Contact Levi & Korsinsky Regarding an Ongoing Investigation — Neutral
CODI Accesswire — May 09, 2025NEW YORK, NY / ACCESS Newswire / May 9, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Compass Diversified ("Compass Diversified") (NYSE:CODI) concerning possible violations of federal securities laws. On May 8, 2025, Compass announced that it intends to delay the filings of its first quarter 2025 Form 10-Q.

Suburban Propane: Secular Challenges And Excess Debt Are Problematic — Negative
SPH Seeking Alpha — May 09, 2025Suburban Propane (SPH) has struggled with excess debt and limited demand growth, resulting in distribution cuts and my cautious outlook on valuation. Despite a favorable Q1 environment, SPH's long-term volume growth is expected to be flat to slightly negative due to rising temperatures and competition. The company is issuing equity to accelerate debt reduction, but distribution increases are unlikely in the next 2-4 years.

PPTA Investors Have the Opportunity to Lead the Perpetua Resources Corp. Securities Fraud Lawsuit with Faruqi & Faruqi, LLP — Neutral
PPTA Accesswire — May 09, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Perpetua To Contact Him Directly To Discuss Their Options NEW YORK CITY, NY / ACCESS Newswire / May 9, 2025 / If you purchased or acquired $50,000 in Perpetua between April 17, 2024 and February 13, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Perpetua Resources …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT — Neutral
SRPT GlobeNewsWire — May 09, 2025NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Sarepta Therapeutics, Inc. (“Sarepta” or the “Company”) (NASDAQ: SRPT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

Shareholders Who Lost Money on PTC Therapeutics, Inc. (PTCT) Should Contact Levi & Korsinsky About Securities Fraud Investigation - PTCT — Neutral
PTCT Accesswire — May 09, 2025NEW YORK, NY / ACCESS Newswire / May 9, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of PTC Therapeutics, Inc. ("PTC Therapeutics, Inc.") (NASDAQ:PTCT) concerning possible violations of federal securities laws. PTC issued a press release on May 5, 2025, "announc[ing] results from the Phase 2 PIVOT-HD study of PTC518 (votoplam) in Stage 2 and Stage 3 Huntington's disease (HD) patients.

Arvinas, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - ARVN — Neutral
ARVN Accesswire — May 09, 2025NEW YORK, NY / ACCESS Newswire / May 9, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Arvinas, Inc. ("Arvinas") (NASDAQ:ARVN) concerning possible violations of federal securities laws. On May 1, 2025, Arvinas issued a press release announcing a re-prioritization of its vepdegestrant development plan and research portfolio.

Levi & Korsinsky Notifies Shareholders of Fluence Energy, Inc. (FLNC) of a Class Action Lawsuit and an Upcoming Deadline — Neutral
FLNC Accesswire — May 09, 2025NEW YORK, NY / ACCESS Newswire / May 9, 2025 / If you suffered a loss on your Fluence Energy, Inc. (NASDAQ:FLNC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fluence-energy-lawsuit-submission-form?prid=147773&wire=1 or contact Joseph E. Levi, Esq.

ATTENTION CABO SHAREHOLDERS: Investors Who Lost Money on Cable One, Inc. are Urged to Contact Levi & Korsinsky about an Ongoing Investigation — Neutral
CABO Accesswire — May 09, 2025NEW YORK, NY / ACCESS Newswire / May 9, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cable One, Inc. ("Cable One, Inc.") (NYSE:CABO) concerning possible violations of federal securities laws. On May 2, 2025, Cable One missed earnings expectations by nearly $8 and suspended its dividend.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY — Neutral
HQY GlobeNewsWire — May 09, 2025NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc (“HealthEquity” or the “Company”) (NASDAQ: HQY). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

Assured Guaranty Ltd. (AGO) Q1 2025 Earnings Call Transcript — Neutral
AGO Seeking Alpha — May 09, 2025Assured Guaranty Ltd. (NYSE:AGO ) Q1 2025 Earnings Conference Call May 9, 2025 8:00 AM ET Company Participants Robert Tucker - Senior MD, IR and Corporate Communications Dominic Frederico - President and CEO Rob Bailenson - COO Ben Rosenblum - CFO Conference Call Participants Marissa Lobo - UBS Tommy McJoynt - KBW Operator Good morning, and welcome to the Assured Guaranty Limited First Quarter 2025 Earnings Conference Call.

Hagerty, Inc. (NYSE:HGTY ) Q1 2025 Earnings Conference Call May 7, 2025 10:00 AM ET Company Participants Jay Koval - Senior Vice President-Investor Relations McKeel Hagerty - Chairman & Chief Executive Officer Patrick McClymont - Chief Financial Officer Conference Call Participants Pablo Singzon - JPMorgan Mark Hughes - Truist Securities Operator Greetings, and welcome to the Hagerty First Quarter 2025 Earnings Call. At this time, all participants are in a listen-only mode.

Crude Oil Price Outlook – Crude Oil Continues to See Base Building — Neutral
BNO DBO GUSH IEO OIH OIL PXJ UCO USO XOP FXEmpire — May 09, 2025The oil market seems to be looking for some reason to go higher, but at this point, we are waiting for the result of the meeting between Chinese and American officials in Switzerland this weekend.
